[
    [
        {
            "time": "",
            "original_text": "贝达药业(300558.SZ)：凯铭投资解质545万股及质押612.5万股、济和创投解质631万股",
            "features": {
                "keywords": [
                    "贝达药业",
                    "凯铭投资",
                    "解质",
                    "质押",
                    "631万股",
                    "545万股",
                    "612.5万股"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "贝达药业(300558.SZ)：凯铭投资解质545万股及质押612.5万股、济和创投解质631万股",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业点评报告：ASCO 2020公布多项临床数据 国内创新蓬勃势起",
            "features": {
                "keywords": [
                    "医药生物",
                    "ASCO",
                    "2020",
                    "临床数据",
                    "国内创新",
                    "蓬勃势起"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业点评报告：ASCO 2020公布多项临床数据 国内创新蓬勃势起",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]